You can find more information about PF3D7_1115300-falcipain 2b using the following links:

PlasmoDB - the Plasmodium genome resource
The TDR Targets Database

Subcellular Localization

Affecting Drugs
Drug Name PubMed Articles (year of publication)
[5-cyclohexa-2,4-dien-1-yl-1-[2-[(2-hydroxy-5-oxo-tetrahydrofuran-3-yl)amino]-2-oxo-ethyl]-2-oxo-3H-1,4-benzodiazepin-3-yl]methyl N-(3-chloro-2-methyl-cyclohexa-2,4-dien-1-yl)carbamate;methanol
[5-cyclohexa-2,4-dien-1-yl-1-[2-[(2-hydroxy-5-oxo-tetrahydrofuran-3-yl)amino]-2-oxo-ethyl]-2-oxo-3H-1,4-benzodiazepin-3-yl]methyl N-(4-methoxycyclohexa-2,4-dien-1-yl)carbamate
[5-cyclohexa-2,4-dien-1-yl-1-[2-[(2-hydroxy-5-oxo-tetrahydrofuran-3-yl)amino]-2-oxo-ethyl]-2-oxo-3H-1,4-benzodiazepin-3-yl]methyl N-[4-chloro-2-(trifluoromethyl)cyclohexa-2,4-dien-1-yl]carbamate;methanol
1,4-benzodiazepine scaffold
Alln
Arylcarbamic acid not derivatives
Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenyl-2-propanyl]amino}-2-butanyl]carbamate
Dibenzyl aziridine
E-64
E-64d
Falcitidin
Fumaric acid
Mg-132
Mu-leu-hph-vsph
Suggested target
Symplostatin
Tcmdc-135965
Thiosemicarbazone
Vinyl sulfone